Immunohistochemical Expression of ROR2 in Gastrointestinal Stromal Tumor

Asmaa Gaber Abdou1, Mona Kandil2, Moshira Abd El Wahed2

  • 1Pathology Department, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt. asmaa_elsaidy@yahoo.com.

PubMed
Abstract

Insights

Gastrointestinal stromal tumor (GIST) patients with ROR2 expression show better survival rates. ROR2 positivity in GIST correlates with reduced tumor progression and favorable prognostic indicators.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the digestive tract, representing 0.1-3% of gastrointestinal cancers.
  • ROR2, a receptor tyrosine kinase, is a signaling receptor for Wnt ligands, implicated in various cellular processes.

Purpose of the Study:

  • To investigate the prognostic significance of ROR2 expression in GIST.
  • To determine the association between ROR2 expression levels and patient survival and tumor progression.

Main Methods:

  • Analysis of 56 paraffin-embedded GIST tissue samples from various gastrointestinal tract locations.
  • Immunohistochemistry technique employed to detect and quantify ROR2 expression in GIST tissues.

Main Results:

  • ROR2 expression was detected in 71.4% of GIST cases studied.
  • Strong ROR2 staining intensity correlated significantly with prolonged overall survival (p=0.048).
  • ROR2 positivity and higher immunostaining percentages inversely correlated with tumor progression.

Conclusions:

  • GIST cases positive for ROR2 expression demonstrate a lower likelihood of disease progression.
  • ROR2 positivity is associated with favorable prognostic characteristics in GIST patients.

Related Concept Videos